| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |